ARTICLE | Company News
ImmunoCellular, Kyowa Hakko Kirin deal
June 6, 2011 7:00 AM UTC
ImmunoCellular received rights from Kyowa's BioWa Inc. subsidiary to use its Potelligent technology to develop ImmunoCellular's antibodies to treat cancer. Potelligent increases antibody-dependent ce...